Sarver Vrooman Wealth Advisors »

Crispr Therapeutics shares owned by Sarver Vrooman Wealth Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Sarver Vrooman Wealth Advisors from 13F filings

Historical chart of Sarver Vrooman Wealth Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Sarver Vrooman Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Sarver Vrooman Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $12k 235 52.44

More positions owned by Sarver Vrooman Wealth Advisors

Ishares Etf Tr Ibonds Dec 2031 Trem Corporate Etf (IBDW)
Schwab Us Dividend Etf Equity Etf (SCHD)
Ishares Tr Etf Ibonds Dec 2026 Term Corp Etf (IBDR)
Wisdomtree Us Qual Etf Dividend Growth Fund Etf (DGRW)
Xtrackers Msci Eafe Etf Equity Etf (DBEF)
Ishares Edge Msci Etf Min Vol Usa Etf Etf (USMV)
Microsoft Corp Stock (MSFT)
Palantir Technologies Inc Cl A Stock (PLTR)
Apple Stock (AAPL)
Spdr S&p 500 Trust Etf Etf (SPY)
Invesco Self-indexed Etf Fd Tr Bulletshares 2030 Mun Fd Etf Etf (BSMU)
Invesco Exch Traded Etf Self Indexed Fd Tr Bulletshares 2027 Mun Bd Etf (BSMR)
Invesco Qqq Tr Etf Unit Ser 1 Etf (QQQ)
Nvidia Corp Stock (NVDA)
Ishares Tr Ibonds Etf Dec 2034 Term Corporate Etf (IBDZ)

View all positions for Sarver Vrooman Wealth Advisors

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Orbis Allan Gray
Capital Research and Management Company - Division 3
State Street Corporation
T. Rowe Price Investment Management
UBS Group
Vanguard Group
Geode Capital Management
Susquehanna International
Sr One Capital Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Citadel Advisors
FMR

View all funds holding Crispr Therapeutics